We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Fisher & Paykel Demonstrates Humidified Nasal High Flow System for Delivering Respiratory Support at MEDICA 2021

By HospiMedica International staff writers
Posted on 18 Nov 2021
Image: Airvo 2 Nasal High Flow System (Photo courtesy of Fisher & Paykel Healthcare)
Image: Airvo 2 Nasal High Flow System (Photo courtesy of Fisher & Paykel Healthcare)

Fisher & Paykel Healthcare (F&P; Auckland, New Zealand) demonstrated its Airvo 2 nasal high flow (NHF) system that is designed to deliver proven respiratory support at MEDICA 2021.

The F&P Respiratory Care Continuum illustrates the breadth of respiratory therapies patients may require when in need of respiratory assistance. NHF is recognized by the WHO for treatment of patients with COVID-19. NHF has been used as respiratory support throughout the pandemic and its use on COVID-19 patients has been observed to keep patients off mechanical ventilation and help them stay off, lower the rate of mortality, and reduce length of stay.

The Airvo 2 is an integrated solution for delivering Optiflow high flow therapy. F&P’s leading humidification technology allows the Airvo 2 to comfortably provide high flows of humidified air (with supplemental oxygen if required) to spontaneously breathing patients, through the unique series of Optiflow interfaces. It features three temperature settings, including 37°C (body temperature pressure saturated for a normothermic patient) i.e. optimal humidity. An integrated flow generator delivers a wide flow range 10 - 60 L/min for adult patients and 2 - 25 L/min for pediatric patients, taking patients from the most acute environments (ICU and ED) to the home.

It also features F&P’s Evaqua technology which reduces the formation of mobile condensate. Oxygen can be added from a wall supply or cylinder. Its in-built ultrasonic oxygen analyzer requires no calibration, service or replacement. No separate temperature probes or heater-wire adapters are required. The Airvo 2, with its wide range of accessories, provides versatility, mobility and convenience. A compact system with a built-in flow generator means there’s no need for a noisy, heavy air compressor in order to use the Airvo 2 for transport. A suitable UPS can be added, and the Airvo 2 is ready to go.

Related Links:
Fisher & Paykel Healthcare 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Ultrasound Needle Guidance System
SonoSite L25
New
Measuring Rod
seca 233

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more